Trademark: 90126310
Status Date
Monday, February 13, 2023
Filing Date
Thursday, August 20, 2020
Published for Opposition
Tuesday, November 17, 2020
Abandoned Date
Monday, February 13, 2023
5 Therapeutic drugs for the treatment of human papilloma virus, human immunodeficiency virus, and a range of severe acute respiratory syndromes
Feb 13, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 13, 2023
Abandonment - No Use Statement Filed
Jul 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 7, 2022
Sou Extension 3 Granted
Jul 7, 2022
Sou Extension 3 Filed
Jul 7, 2022
Sou Teas Extension Received
Jan 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2022
Sou Extension 2 Granted
Jan 4, 2022
Sou Extension 2 Filed
Jan 4, 2022
Sou Teas Extension Received
Jun 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2021
Sou Extension 1 Granted
Jun 14, 2021
Sou Extension 1 Filed
Jun 14, 2021
Sou Teas Extension Received
Jan 12, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 17, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2020
Published For Opposition
Oct 28, 2020
Notification Of Notice Of Publication E-Mailed
Oct 15, 2020
Examiner's Amendment Entered
Oct 15, 2020
Assigned To Lie
Oct 15, 2020
Approved For Pub - Principal Register
Oct 15, 2020
Notification Of Examiners Amendment E-Mailed
Oct 15, 2020
Examiners Amendment E-Mailed
Oct 15, 2020
Examiners Amendment -Written
Oct 14, 2020
Assigned To Examiner
Sep 23, 2020
New Application Office Supplied Data Entered
Aug 24, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24